Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-01-29 @ 12:08 PM
Study NCT ID:
NCT03101566
Status:
COMPLETED
Last Update Posted:
2022-10-28
First Post:
2017-03-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-30
First Submit QC Date:
None
Study First Post Date:
2017-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-28
Results First Submit QC Date:
None
Results First Post Date:
2021-08-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-08-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-09-29
Last Update Post Date:
2022-10-28
Last Update Post Date Type:
ACTUAL